We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Marlowe Plc | LSE:MRL | London | Ordinary Share | GB00BD8SLV43 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.00 | 0.39% | 510.00 | 506.00 | 514.00 | 510.00 | 507.00 | 509.00 | 44,459 | 11:29:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 465.7M | -3.8M | -0.0393 | -129.77 | 493.55M |
TIDMMRL
RNS Number : 9132C
Marlowe PLC
04 October 2018
4 October 2018
Marlowe plc
Acquisition of Tersus Consultancy Limited
Marlowe plc ("Marlowe" or the "Group"), the support services group focused on acquiring and developing companies that provide critical testing and maintenance services, announces that it has acquired Tersus Consultancy Limited ("Tersus") for an enterprise value of GBP3.7 million.
Formed in 1986, Tersus provides testing and inspection services to a wide range of clients in both the private and public sectors, mainly focused on managing the risk of asbestos. Tersus, which employs approximately 180 staff, is headquartered in Rainham, Essex, and operates nationally from eight sites, each with its own laboratory.
Tersus' services are complementary to the activities carried out by Marlowe's existing Water Treatment and Air Hygiene division and will enable Marlowe to extend the health and safety and risk management services it provides to customers.
For the year to 31 December 2017, Tersus generated revenues of GBP8.1 million, the majority of which were contracted recurring testing and inspection revenues, adjusted EBITDA of GBP0.9 million, statutory loss before tax of GBP2.6 million reflecting exceptional intercompany write offs of GBP3.2 million and at completion had adjusted net assets of GBP2.1 million. The consideration has been funded from the Group's existing cash resources.
For further information:
Marlowe plc www.marloweplc.com Alex Dacre, Chief Executive Tel: +44 (0) 203 841 6194 Mark Adams, Group Finance Director IR@marloweplc.com Cenkos Securities plc (Nominated Adviser and Broker) Nicholas Wells Tel: +44 (0)20 7397 8900 FTI Consulting Nick Hasell Tel: +44 (0)20 3727 1340 Alex Le May
About Marlowe plc
Marlowe is an AIM-listed company formed to create sustainable shareholder value through the acquisition and development of businesses that provide critical testing & maintenance services in the UK. It is focused on fire protection, security systems, water treatment and air quality services - which are essential to its customers' operations and invariably governed by regulation, and where customers require a single specialist outsourced provider with nationwide coverage. Our customers can be found on most high streets, in office complexes and industrial estates, and include SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACQFKNDNKBDBFKK
(END) Dow Jones Newswires
October 04, 2018 02:00 ET (06:00 GMT)
1 Year Marlowe Chart |
1 Month Marlowe Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions